Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
55.0% inhibition at 0.004 mM, competitively inhibits the enzyme by binding to the active site, have a protective effect against reactive oxygen species in cells, structure-function relationship, computational molecular docking, overview
-
COMT from liver, using 2-hydroxyestradiol as substrate, in Tris-HCl buffer (10 mM, pH 7.4), at 37°C; COMT from liver, using 4-hydroxyestradiol as substrate, in Tris-HCl buffer (10 mM, pH 7.4), at 37°C
-
down-regulation of expression of PP2A catalytic subunit in cells treated with caffeic acid phenethyl ester at 48 h
-
71.8% inhibition of recombinant enzyme at 5 mM, 80% at 10 mM, 50% at 03125 mM
-
99.7% inhibition at 5 mM
-
CAPE, does not chelate HpPDF and does not disrupt the metal-dependent catalysis
CAPE, an active component of propolis, 75% inhibition at 0.01 mM, the competitive inhibitor blocks the substrate entrance, preventing substrate from approaching the active site, but CAPE does not have chelate interaction with HpPDF and does not disrupt the metal-dependent catalysis
reduces the enzyme activity in vivo, suppresses the induction of the enzyme by cisplatin in vivo
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
The activities of liver adenosine deaminase, xanthine oxidase, catalase, superoxide dismutase enzymes and the levels of malondialdehyde and nitric oxide after cisplatin toxicity in rats: protective effect of caffeic acid phenethyl ester
2005
Yilmaz, H.R.; Sogut, S.; Ozyurt, B.; Ozugurlu, F.; Sahin, S.; Isik, B.; Uz, E.; Ozyurt, H.
Toxicol. Ind. Health
21
67-73
Protein phosphatase 2A (PP2A) has a potential role in CAPE-induced apoptosis of CCRF-CEM cells via effecting human telomerase reverse transcriptase activity
2007
Avci, C.B.; Sahin, F.; Gunduz, C.; Selvi, N.; Aydin, H.H.; Oktem, G.; Topcuoglu, N.; Saydam, G.
Hematology
12
519-525
Structure-activity relationship of C6-C3 phenylpropanoids on xanthine oxidase-inhibiting and free radical-scavenging activities
2007
Chang, Y.C.; Lee, F.W.; Chen, C.S.; Huang, S.T.; Tsai, S.H.; Huang, S.H.; Lin, C.M.
Free Radic. Biol. Med.
43
1541-1551
Inhibition of human catechol-O-methyltransferase (COMT)-mediated O-methylation of catechol estrogens by major polyphenolic components present in coffee
2009
Zhu, B.T.; Wang, P.; Nagai, M.; Wen, Y.; Bai, H.W.
J. Steroid Biochem. Mol. Biol.
113
65-74
Caffeic acid phenethyl ester (CAPE), an active component of propolis, inhibits Helicobacter pylori peptide deformylase activity
2013
Cui, K.; Lu, W.; Zhu, L.; Shen, X.; Huang, J.
Biochem. Biophys. Res. Commun.
435
289-294
Effect of bile salt hydrolase inhibitors on a bile salt hydrolase from Lactobacillus acidophilus
2014
Lin, J.; Negga, R.; Zeng, X.; Smith, K.
Pathogens
3
947-956
Discovery of bile salt hydrolase inhibitors using an efficient high-throughput screening system
2014
Smith, K.; Zeng, X.; Lin, J.
PLoS ONE
9
e85344
-
Biochemical characteristics of three feruloyl esterases with a broad substrate spectrum from Bacillus amyloliquefaciens H47
2017
Wang, X.; Bai, Y.; Cai, Y.; Zheng, X.
Process Biochem.
53
109-115
Peptide deformylase a new target in antibacterial, antimalarial and anticancer drug discovery
2015
Sangshetti, J.; Khan, F.; Shinde, D.
Curr. Med. Chem.
22
214-236